Monthly Archives: November 2023

Global Infectious Diseases Collaboration and Licensing Agreements Analysis Report 2023: Company A-Z, Headline Value, Upfront, Milestone, Royalties, Therapeutic Area, Technology Type

Dublin, Nov. 16, 2023 (GLOBE NEWSWIRE) — The “Infectious Diseases Collaboration and Licensing Deals 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Infectious Diseases Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious diseases deals entered into by the worlds leading biopharma companies. This fully revised and updated report offers […]

Public healthcare system utilization for chronic hepatitis C infection in Vietnam

Adamson J, Ben-Shlomo Y, Chaturvedi N, Donovan J. Ethnicity, socio-economic position and gender–do they affect reported health-care seeking behaviour? Soc Sci Med. 2003;57(5):895–904. Article  PubMed  Google Scholar  Oberoi S, Chaudhary N, Patnaik S, Singh A. Understanding health seeking behavior. J Family Med Prim Care. 2016;5(2):463–4. Article  PubMed  PubMed Central  Google Scholar  Levesque J-F, Harris MF, […]

Re-writing infection prevention and disease control for Australia

Professor Shaban, along with his team, played a pivotal role in identifying and managing the first cases of COVID-19 in New South Wales at Westmead Hospital.  “Towards the end of 2019, my team and I began receiving information through our networks about the emergence of a new pathogen, initially referred to as the novel coronavirus,” […]

The efficacy and safety of multi-loop traction device for gastric endoscopic submucosal dissection: a single center prospective pilot study

Abstract Although gastric endoscopic submucosal dissection (ESD) is widely used, the degree of difficulty varies greatly depending on the lesion. Since the multi-loop traction device (MLTD) has been suggested to shorten the procedure time in colorectal ESD, we examined the efficacy and safety of using the MLTD in gastric ESD. Thirty patients with gastric neoplasms […]

Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review

Vijay K, Neuen BL, Lerma EV. Heart failure in patients with diabetes and chronic kidney disease: challenges and opportunities. Cardiorenal Med. 2022;12(1):1–10. Article  CAS  PubMed  Google Scholar  Fontes-Carvalho R, Santos-Ferreira D, Raz I, Marx N, Ruschitzka F, Cosentino F. Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin. Eur […]

UK approves world-first gene-editing treatment for blood disorders | Imperial News

UK becomes the first country to approve CRISPR gene therapy treatment for two inherited blood disorders. The UK has become the first country in the world to approve a gene therapy as a potential cure for two inherited blood disorders. The new therapy, called Casgevy, is based on CRISPR gene editing and has been authorised […]